5-Cyclopropyl-1 H -pyrazole-3-carboxylic acid hydrazide, 95.0%, 250mg

3-Hydroxy-N-(naphthalen-1-yl)-2-naphthamide, 98%, 5g

1-(3,4-Dimethylphenyl)ethanone, 95.0%, 25g

2-((((9h-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(5-chloro-1h-indol-3-yl)propanoic acid, 97%, 100mg

4,6-Dichloro-N-methoxy-N-methyl-pyridine-3-carboxamide, 98+%, 5g

(S)-(-)-NBD-Pro-COCl [=(S)-(-)-4-Nitro-7-(2-chloroformylpyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]>95.0%(HPLC)(qNMR)100mg

3,4-Dihydro-8-(trifluoromethyl)-2H-1,4-benzoxazine, 1g

2-METHYL-5-(2-THIENYL)-3-FURANCARBOXYLIC ACID, 95%, 100mg

1-((2R)PYRROLIDIN-2-YL)-4-METHOXYBENZENE, 95.0%, 250mg

5-Bromo-2-methoxy-4-(methylthio)pyridine, 95+%, 5g

1-Benzhydrylazetidin-3-one, 95.0%, 10g

5-Bromo-1H-indene, 95.0%, 1g

1-Hydroxy-6-(trifluoromethyl)benzotriazole, 98.0%, 10g